we examined hb f in 13 patients with myeloproliferative disease ( six polycythemia vera , five polycythemia vera with myeloid metaplasia , one agnogenic myeloid metaplasia , and one chronic myelogenous leukemia ) who were treated with hydroxyurea .
C0027022
myeloproliferative
C0001815
agnogenic myeloid metaplasia